DrugPatentWatch Database Preview
Profile for Canada Patent: 2563086
US Patent Family Members and Approved Drugs for Canada Patent: 2563086
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Oct 15, 2029 | Alkermes | VIVITROL | naltrexone |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |